PHIO
Closed
Phio Pharmaceuticals Corp
2.48
+0.13 (+5.53%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 2.35
Day's Range: 2.3032 - 2.53
Send
sign up or login to leave a comment!
When Written:
5.71
Phio Pharmaceuticals Corp is a biotechnology company that focuses on developing RNA interference (RNAi) therapeutics for the treatment of cancer and other diseases. The company's proprietary RNAi technology platform, called "sd-rxRNA," enables the design and development of RNAi molecules that are more potent and specific than traditional RNAi molecules.
Phio Pharmaceuticals' pipeline includes several sd-rxRNA-based drug candidates, including PH-762, PH-894, and PH-797804, which are being developed for the treatment of various cancers, including melanoma, renal cell carcinoma, and ovarian cancer.
The company was founded in 2007 and is headquartered in Marlborough, Massachusetts.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Phio Pharmaceuticals' pipeline includes several sd-rxRNA-based drug candidates, including PH-762, PH-894, and PH-797804, which are being developed for the treatment of various cancers, including melanoma, renal cell carcinoma, and ovarian cancer.
The company was founded in 2007 and is headquartered in Marlborough, Massachusetts.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








